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Abstract - With the emergence and rapid advancement of DNA 
microarray technologies, construction of gene expression 
profiles for different cancer types has already become a 
promising means for cancer diagnosis and treatment. Mosl 
previous research has focused on binary classification. Here, we 
use a probabilistic neural nehvork (PNN) for multi-classification 
of cancer data. The experimental results demonstrate the 
effectiveness of the  PNN in addressing gene expression data. 
I INTRODUCTION 
With the emergence and rapid advancement of DNA 
microarray technologies [ 1-21, cancer classification through 
identifying the corresponding gene expression profiles has 
already attracted numerous efforts from a wide variety of 
research communities [3-161. Cancer classification is 
important to the subsequent diagnosis and treatment. Without 
the correct identification of cancer types, it is rarely possible 
to provide useful therapies and achieve expecting effects. 
Traditional classification methods are largely dependent on 
morphological appearance of tumors, and their applications 
are limited by the existing uncertainties [3]. Tumors with 
similar appearance may have quite different origins and 
therefore respond differently for the same treatment therapy. 
For example, in diffuse large B-cell lymphoma (DLBCL), 
almost half of clinical cases fail to the treatment due to the 
existence of unknown subtypes that cannot be discriminated 
by their morphologic parameters [4]. DNA microarray 
technologies offer caner researchers a new way to investigate 
the pathologies of cancer from the molecular angle, and 
further, to make more accurate predictions in prognosis and 
treatment. 
There exist different types of microarray technologies 
based on the nature of the attached DNA (cDNA with length 
varying from several hundred to thousand bases or 
oligonucleotides containing 20-30 bases). For cDNA 
technologies, a microarray consists of a solid substrate to 
which a large amount of cDNA clones are attached according 
to some certain order [I] .  Fluorescently labeled D N A ,  
obtained from RNA samples of interest (e.g. tumor samples) 
through the process of reverse transcription, is hybridized 
with the array. A reference sample (e.g. normal samples) with 
a different fluorescent label is also required for the purpose of 
comparison. Image analysis techniques are then used to 
measure the fluorescence of each dye after the genes are 
washed off. The resulting ratio reflects relative levels of gene 
expression. For high-density oligonucleotide microarray, 
oligonucleotides are fixed on a chip through techniques like 
photolithography and solid-phase DNA synthesis [2]. With a 
wealth of gene expression data at hand, researchers have 
more opportunities, while inevitably facing new challenges. 
Gene expression data sets usually have features like high 
dimensionality, high redundancy and inherent noise, which 
ask for the computational analysis methods to have 
corresponding mechanism to deal with them. Research on 
gene expression data is summarized in three levels, according 
to the task complexity [17]. The bottom level investigates the 
activities of single genes under different conditions or tissues. 
The second level focuses on the relations and interactions 
among genes and conditions. The top level attempts to infer 
the whole genetic network that finally determines all the 
pattems we observed. The tumor classification researches 
based on gene expression data can be classified into the 
intermediate level, which explores the relations between 
types of tumors and gene markers. 
This kind of research has already been reported in the 
literature with promising results [3-161. Golub et al. deemed 
cancer classification as two challenges: class discovely and 
class prediction and used several strategies: including 
weighted voting, neighborhood analysis and self-organizing 
feature maps (SOFMs) to discriminate two types of human 
acute leukemias (ALL vs. AML) [3]. According to their 
results, two subsets of acute lymphoblastic leukemia (ALL), 
with different origin of lineage, are also well separated. 
Alizadeh et al. distinguished two molecularly distinct 
subtypes of diffuse large B-cell lymphoma by their gene 
expression profiles [4]. Alon et al. performed a two-way 
clustering for both colon tissues and genes and revealed the 
potential relations between them [5] .  Other explorations 
include ovarian cancer [6], breast cancer [7], cutaneous 
melanoma [PI, and so on. For most of the researches 
aforementioned, hierarchical clustering (HC) is employed. 
Although HC has the advantage such as informative 
visualization of the clustering results and the versatility, it 
lacks robustness and does not have favorable scalability 
properties. We have used a new family of neural network 
architecture - Ellipsoid ART and ARTMAP (ENEAM) to 
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analyze several publicly accessible data sets [ I  I]. EA/EAM 
has the properties of fast, stable and finite learning and can 
create hyper-ellipsoidal clusters with complex nonlinear 
boundaries. Other examples include graph theory-based 
methods [IO], singular value decomposition with Bayesian 
models [9], partial least squares combined with logic 
discrimination and quadratic discriminant analysis [I41 and 
support vector machines (SVMs) [16]. 
In practice, it is common to discriminate more than two 
types of cancers. Ramaswamy et al. divided the multi-class 
problem as a series of binary classification sub-problems 
through either one-versus-all or all-pairs approach [ 18-19]. 
SVMs, weighted voting and k-nearest-neighbors algorithm 
were then used to perform binary classification and the final 
label was decided according to some confidence values. Khan 
trained perceptrons to categorize small round blue-cell 
tumors (SRBCTs) with 4 subclasses [ 121. A nearest shrunken 
centroid method was proposed by Tibshirani et al. and was 
tested on the SRBCT data set with 100% accuracy [13]. 
Furthermore, Scherf et al. constructed a gene expression 
database to study the relationship between genes and drugs 
for 60 human cancer cell lines originating from I O  different 
tumors, which provides an important criterion for therapy 
selection and drug discovery [15]. 
In our study, we use the probabilistic neural network 
(PNN) [21] to address the problem of multiple tuinor 
classification without the need to divide it into binary sub- 
problems. As a powerful tool developed to approximate the 
Bayesian decision rule, PNN has already shown appealing 
performance in a large number of applications [22-241. Here, 
we further demonstrate the potential and effectiveness of 
PNN in addressing the challenges of gene expression data 
analysis with promising results based on several publicly 
accessible data sets on cancer researches. 
The paper is organized as follows. Section I 1  presents a 
brief introduction to PNN. Section 111 describes the data sets 
and experimental methods. The experimental results are 
presented and discussed in section IV and section V 
concludes the paper. 
11. PROBABILISTIC NEURAL NETWORKS 
Probabilistic neural networks were first introduced by 
Specht [21] as an implementation of nonparametric Pazen 
window estimation with feed-forward neural network 
architecture. A typical PNN architecture is illustrated in Fig. 
1, which consists of three layers, known as input layer, 
pattern layer and category layer [20, 241. The input layer 
works as a distribution mechanism and receives input 
components from the data set. Therefore, the number of 
nodes in this layer is equal to the dimension of the input 
vector. All of these nodes are fully connected with the nodes 
in the pattern layer, which is considered as the key of PNN. 
The PNN requires n pattern nodes if the total number of 
training pattems is n , so that each pattern node can he 
regarded as corresponding to a training pattern. Different 
from link between input and pattern layer, the nodes of 
pattern and category are sparsely connected. Each pattern 
node is only connected to the category node that correctly 
indicates the its associated class. 
X i  x, XP 
Fig. I .  PNN architccturc. Each patlcrii nodc rcprcscnls a partcm in thc 
training sct. Thc Baycaian postcrior probability for cach catcgory is obtaincd 
as thc output of tho corrcsgonding category nodc. 
The PNN calculates the Bayesian posterior probability for 
each category. During the training phase, the weights 
connecting the input and pattern layer are simply set as the 
copy of input vectors, i.e. w i  = x , , f o r i =  I ,..., n . As 
mentioned before, each pattern node merely has connection 
with the category node representing the class of the 
corresponding pattem. The process is one of the fastest in 
known training strategies. However, the cost for the time 
efficiency is the storage complexity, one pattem unit is 
required for each pattern in the entire training set, which 
causes problems when dealing with large volume of data sets. 
One of potential solutions is to group training pattems into a 
series of clusters and only use the centroid of each cluster to 
supervise the network learning [25]. 
During the test or classification phase, each pattern node 
performs a dot product operation with a new pattern vector 
x and a weight vector w i  , expressed as Pi = X * W ,  . The 
final output of pattern layer is obtained via a nonlinear 
transformation. Usually a Gaussian activation 
function, exp((P, - 1) / 02), is used, though other alternatives 
are also available [21]. Here, o is the smoothing parameter 
of the Gaussian kernel and is also the only one parameter that 
is dependent on the users to decide. It has great effect to the 
formation of resulting decision boundary and the strategy on 
how to select appropriate a was discussed in details by 
Specht in [21]. Note that if both the training patterns 
(equivalent to weight vectors) and the new pattems are 
normalized to unit length, the output of pattern layer can he 
represented as 
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exp((pi - l ) /u2)  
= exp(-(x - w i ) ~ ( x  -w i )  / 2c2) 
=exp(-(x'x+wi T w i  -2x T w i ) / 2 u 2 ) ,  
which is identical to the Parzen window function [21]. In this 
sense, each pattern node provides the corresponding category 
node with the class conditional probability given the training 
pattern. These values are then summed up in the category 
layer for each category as the estimated probability for the 
new pattern. The label of the pattem can be predicted by just 
choosing the maximum probability. 
Due to its design, PNN displays many desirable properties 
and characteristics in the context of pattem classification. 
Among all of those features, the fast training is most 
appealing. The training rule is very simple and can be used in 
online learning. Only one pass of the training data is required 
under the training scheme. Though PNN sacrifices the space 
efficiency for it, the cost can be decreased to certain extent 
with the introduction of clustering techniques [25].  Also, the 
structure of PNN makes it very easy to achieve parallel 
implementation. Another important feature of PNN is the 
fewer user-dependent parameters compared with other 
classifiers. There is only one Gaussian kernel width 
parameter a relying on the selection of the users. According 
to [ZI] and our experiments, it is not difficult to find 
appropriate a and the experimental results are not sensitive to 
the small changes of a. Moreover, PNN puts the 
nonparametric statistical approach into a neural network 
framework and provides the output of the neural network 
with a new interpretation, i.e. through the form of conditional 
probability density function. The resulting probability for 
each category makes it possible to investigate the confidence 
of assigning a new pattern to a class. Finally, PNN has the 
ability to approximate Bayesian optimal decision surfaces 
that can be arbitrarily complex. 
111. DATA SETS AND EXPERIMENTS 
We use two data sets to test PNN performance in multiple 
cancer classification. 
SRBCT data set. This data set is on the diagnostic 
research of small round blue-cell tumors (SRBCTs) of 
childhood and consists of 83 samples from four categories, 
known as Burkitt lymphomas (BL), the Ewing family of 
tumors (EWS), neuroblastoma (NB) and rhabdomyosarcoma 
(RMS) [12]. 5 non-SRBCT samples are also included in the 
original data set for testing the ability of diagnosis rejection, 
hut we do not use them in our study. Gene expression levels 
of 6567 genes were measured using cDNA microarray for 
each sample, 2308 of which passed the filter that requires the 
red intensity of a gene to be greater than 20 and were kept for 
further analyses. The relative red intensity (RRI) of a gene is 
defined as the ratio between the mean intensity of that 
particular spot and the mean intensity of all filtered genes and 
the ultimate expression levels measure is the natural 
logarithm of MI. The data are expressed as a 
matrix E = {ei,j}s3x230a, where e, , j  represents the expression 
level of gene j in tissue sample i 
GCM14 data set. This data set is available at http://www- 
genome.wi.mit.eddcgi-bin/cancer/dalasets.cgi. There are 14 
different tumor types, consisting of breast, prostate, lung, 
colorectal, lymphoma, bladder, melanoma, uterus, leukemia, 
renal, pancreas, ovary, mesothelioma, and CNS cancer, with 
218 samples. These samples are divided into three groups in 
the original research, 144 for training, 54 for testing, and the 
rest 20 as poorly differentiated (PD) tumors. Also, 90 normal 
tissue samples are included for the study of discriminating 
tumor and normal tissues. In our experiments, we only work 
on the 198 tumor samples in the original training and test 
sets. Gene expressions for 16,063 genes were measured using 
oligonucleotide microarrays. The final matrix is in the form 
of E = ~ei,jl~18x16~63. 
Gene selection. From the above description of the two data 
sets used in the paper and other public data sets [3-81, it can 
he seen that one of the common feature is the overwhelming 
number of measures of gene expression levels compared with 
the number of samples. Not all of these genes are relevant to 
the discrimination of tumors and sometimes, only a small part 
of them is enough for correct classification [3, I l l .  The 
existence of more genes that do not contribute to the 
distinction in the data sets not only increases the 
computational complexity, hut impairs the effects of those 
relevant ones to some extent. Furthermore, cancer researches 
also require identifying the relation of tumors and their 
causes in the molecular level, which is imperative in 
determining appropriate therapy. Therefore, feature selection 
or extraction, also known as informative gene selection, is 
critically important in this context. 
Principal component analysis (PCA) is a widely used tool 
for dimension reduction, which attempts to seek the 
projection that best interpret the variation of the data [ZO]. 
PCA has already been used in some applications on gene 
expression data [U]. But according to the experimental 
results in [26], PCA cannot always find the correct structure 
with just the first few principal components and therefore is 
not recommended under general cases. Several other methods 
based on ranking genes according to their expression 
differentiation under two different classes (represented as + I  
and -1 here) have been proposed, examples including: 
( I )  Discrimination score [3]: 
P+ (i) - P- (4 D(i) = 
u+(i)+u-(i) ' 
where p+(i )  and p-( i )  are the mean values of gene i for 
the samples in class + I  and class -1, and u+(i) and 
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o_(i)are  the standard deviations of gene i for the samples 
in class +I and -1. 
(2) 1-statistics score [14]: 
where n, and nI are the sizes for samples in the two classes. 
(3) TNoM score [IO]: 
' TNoM(i,/) = minErr(d,t j i , / ) ,  
d.1 
where d is the class label parameter, t represents the 
threshold of the gene i , 1, is the label of the kth sample, and 
Err(d,f 1 i , / )  = t sign(d(ek, - t ) ) )  is the number of 
k 
errors of a decision stump rule. 
According to some experimental studies, most of these 
methods intend to choose the similar subsets of genes and do 
not greatly affect the performance of the classifiers. Thus, we 
employed the first criterion to select informative genes. The 
only change is that we just use the absolute value of the 
score. So it reflects the expression level difference between 
the two classes for each gene. Gene expresses itself most 
differently in two classes will have the highest score. Since 
our final goal is to classify multiple types of cancer, we 
utilize a one-versus-all strategy to seek gene predictors. In 
other words, for a C-class prediction problem, we compare a 
particular class with the other C-I classes that are considered 
as a whole. We can just select genes according to their 
contribution to distinguish each class, or the total score for 
each gene is summed over all C comparison and the top 
genes are selected with the highest scores. Of course, 
painvise strategy can also be used, which performs 
comparisons between each pair of classes. 
(3 
Experiment designs. Since the data sets consist of only a 
small number of samples, it is better to use the jackknife 
approach, which is also called leave one out cross validation 
(LOOCV), to examine the performance of the classifier. For a 
data set with n samples, the classifier is trained n times. Each 
time, a.different single sample is lefl out as the test point and 
the other n-I samples are used to train the classifier. 
Performance evaluation of the classifier is estimated by 
considering the average accuracy of the n cross-validation 
experiments. 
We summarize OUI experimental procedure with the 
following steps. First, normalize the input pattems to unit 
length. Then, two strategies are used. For the first strategy, 
we rank and select a set of informative genes with the 
adementioned criterion across all samples, and perform the 
LOOCV operation with one sample left out for test and the 
others for training in the learning and prediction phase. This 
method does not consider the effect of bias for gene selection 
I 
and is regarded as too optimistic [9 ] .  The second strategy 
aims to overcome the bias by selecting informative genes at 
each step of LOOCV operation. Therefore, genes selected in 
the subset may be different for each stage. But generally, 
these gene subsets are highly overlapping, with only a small 
portion of difference observed. The experimental results are 
illustrated and depicted in the next section. 
IV. RESULTS 
Fig. 2 describes the classification accuracy for the SRBCT 
data set with the selection of different numbers of gene 
predictors. We illustrate the results for both the bias included 
and free strategy here. From the figure, we can see that there 
is just some minor decrease in the performance when bias 
free method was used. This shows that the effect of selection 
bias may not he very critical in the case of LOOCV 
procedure because of the high overlapping of gene subsets. 
We also can see the importance of informative genes 
selection in tumor classification. The PNN classifier can 
achieve 100% accuracy when only top 50 genes are chosen. 
If the subset is increased to include all genes in the data set or 
to another extreme, reduced to just comprise several genes, 
the accuracy will decrease in both cases, though not much. 
These suggest that too many or too few genes both deteriorate 
the perfomiance of the classifier. Many genes are not related 
to the classification and including them in the data set will 
bring noise into the classification system. On the other hand, 
important information will be wrongly discarded with 
inadequate genes chosen. These results are consistent with 
those reported in [I21 and [13]. 
Fig. 3 shows the effects of the smoothing parameter o to 
the classification accuracy, when top 100 gene markers are 
selected with selection bias free strategy, or all genes are 
used. Obviously, it is not difficult to find a kernel width o 
that can lead to a satisfying result. With the increase of the 
dimensionality, the effective 0 tends to become larger in 
order to provide better interpolation. 
Fig. 2. The classification accuracy as a function of the number of informarivc 
nenes. 
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Fig. 3. Thc classification accuracy as a function do. 
The best performance we obtain for the GCM14 data set is 
summarized in Table I, in which the numbers along the 
diagonal indicate the correct assignment of samples by PNN. 
For each one-versus-all comparison, top IO genes are selected 
and the corresponding total number of genes is 138. The 
accuracy is around 75.3% and can be compared with the 
result reported in the original paper that constructs a multi- 
class prediction scheme consisting of 14 SVMs [18]. From 
the table, we also can observe that PNN can correctly classify 
most of cases for tumor types like colorectal, lymphoma, 
leukemia, mesothelioma and CNS. But for bladder, renal and 
ovary cancer, the classifier cannot effectively discriminate 
them from other tumor types. The analysis is also supported 
by other methods such as SOFMs and SVMs [18]. 
TABLE I. CONFUSION MATRIX OF PNN FOR 14 TUMOR TYPES: 
OVERALL ACCURACY IS 75.3% 
Since PNN has the mechanism that can estimate the 
confidence of the predictions, it provides us a way to evaluate 
the results by comprehensively considering these values. 
Table 11 lists the predicted results with the first three largest 
confidence values. Almost half of the errors are caused due to 
the reason that the confidence value for the correct category 
is ranked second or third by the classifier. This suggests that 
it is more effective and accurate to make predictions by 
combining the information of confidence values. 
V. CONCLUSIONS 
Cancer classification is critically important for prognosis 
and treatment. Microarray technologies provide a new and 
effective avenue to address the problem, while bringing many 
challenges. Here, we utilized the probabilistic neural network 
to distinguish tumor tissues with more than two categories, by 
analyzing gene expression profiling. Because of some 
limitations in conditions like sample collections, almost all of 
the publicly accessible data sets merely include a small set of 
samples for each tumor type, in contrast to the rapidly and 
persistently increasing capability of gene chip technologies 
that also follow the Moore's law [27]. The initial 
experimental results demonstrate the potential of PNN, 
combined with feature selection technique, in extracting 
useful information from these high-dimensional data sets. 
More experiments will be performed for further evaluation 
with richer data available. In the meantime, new feature 
selection approaches are required in order to find informative 
genes that are more efficient in prediction and prognosis. 
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